Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (FERWON-IDA)

Next Previous
X
Search
Trial Profile

A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (FERWON-IDA)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric derisomaltose (Primary) ; Iron sucrose
  • Indications Iron deficiency anaemia
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms FERWON IDA
  • Sponsors Pharmacosmos

    • Most Recent Events

    • 15 May 2021 Results (n=167)of sub analysis evaluating the efficacy and safety of Ferric derisomaltose in patients aged 65 years old, presented at the 2021 Annual Scientific Meeting of the American Geriatrics Society
    • 17 Jun 2019 According to a Pharmacosmos media release, the pre-specified pooled safety analyses of the FERWON-NEPHRO and FERWON-IDA studies, were presented at the 56th ERA-EDTA congress.
    • 17 Jun 2019 Results from the pre-specified pooled safety analyses of the FERWON-NEPHRO and FERWON-IDA studies, presented in a Pharmacosmos media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top